Research program director facilitating cross-organization collaborative initiatives spanning pharma, academia, and global regulatory agencies — driving biomarker qualification, program strategy, and operational execution from concept to regulatory acceptance.
Recent work includes FDA qualification of GLDH as a clinical safety biomarker and contributions recognized as the 2025 Toxicological Sciences Paper of the Year.
Served as an English language educator in Cape Verde, teaching across high school and university levels in multilingual settings. Also coordinated library development and contributed to international development reporting at the Instituto Superior de Educação (ISE).